Table 1 Clinicopathological characteristics in patients with colorectal cancer: univariate survival analysis
Patients (n=147) | Hazard ratio (95% CI) | P-value | |
|---|---|---|---|
Age group (<65/65–74/⩾75) | 46/44/57 | 2.33 (1.42–3.83) | <0.001 |
Sex (male/female) | 78/69 | 2.11 (1.03–4.36) | 0.043 |
Site (colon/rectum) | 105/42 | 1.38 (0.60–3.21) | 0.451 |
Dukes stage (B/C) | 91/56 | 5.07 (2.33–11.02) | <0.001 |
Albumin (<35/⩾35 g l−1) | 31/116 | 0.86 (0.33–2.26) | 0.766 |
C-reactive protein (<10/⩽10 mg l−1) | 94/53 | 5.02 (2.35–10.74) | <0.001 |
Tumour characteristics | |||
Diameter (tertiles) | 49/49/49 | 1.02 (0.67–1.56) | 0.927 |
Ulceration (no/yes) | 72/75 | 1.20 (0.59–2.43) | 0.611 |
Differentiation (well/moderate/poor) | 18/116/13 | 1.57 (0.70–3.50) | 0.274 |
Lymphatic invasion (negative/positive) | 124/22 | 1.83 (0.79–4.26) | 0.158 |
Venous invasion (negative/positive) | 118/28 | 2.43 (1.14–5.16) | 0.021 |
Adjuvant therapy (no/yes) | 116/31 | 1.13 (0.49–2.62) | 0.779 |
